Amir R Jafri

Address:

11455 Bissonnet St APT 622, Houston, TX 77099

VIN:

4T1BE46K07U154183

Make:

TOYOTA

Model:

CAMRY

Year:

2007

US Patent:

20120029311, Feb 2, 2012

Filed:

Jul 27, 2010

Appl. No.:

12/844780

Inventors:

MARK RAPTIS - Valley Center CA, US
Amir Jafri - San Diego CA, US
Ganesh Kathiresan - Osterley, GB
Alison Burdett - Oxford, GB

Assignee:

CareFusion 303, Inc. - San Diego CA

International Classification:

A61B 5/00

US Classification:

600301

Abstract:

A vital-signs patch for a patient monitoring system that includes a housing containing a sensor that makes physiological measurements of a patient, a transmitter, a receiver, a memory, and a processor. The processor periodically takes a measurement from the sensor, converts the measurement to a data record, and stores the data record in the memory. Upon receipt of a signal from another device, the processor retrieves at least a portion of the data record, converts the retrieved portion of the data record to a vital-sign signal, and causes the transmitter to transmit the vital-sign signal to the other device.

US Patent:

20120029312, Feb 2, 2012

Filed:

Jul 27, 2010

Appl. No.:

12/844781

Inventors:

Serge Beaudry - St-Lambert, CA
Amir Jafri - San Diego CA, US

Assignee:

CareFusion 303, Inc. - San Diego CA

International Classification:

A61B 5/00
G06F 7/04

US Classification:

600301, 340 58

Abstract:

Systems and methods of tracking a patient within a facility via a vital-signs patch attached to the patient are disclosed. A first signal is received from a bridge, the first signal comprising information indicative of a vital-signs patch attached to a patient. The patient is identified based at least in part on the information. Location of the patient is determined based on a known location of the bridge within the facility.

US Patent:

20120029315, Feb 2, 2012

Filed:

Jul 27, 2010

Appl. No.:

12/844796

Inventors:

Mark Raptis - Valley Center CA, US
Amir Jafri - San Diego CA, US
Alison Burdett - Oxford, GB
Ganesh Kathiresan - Osterley, GB

Assignee:

CareFusion 303, Inc. - San Diego CA

International Classification:

A61B 5/00

US Classification:

600301

Abstract:

A vital-signs patch in a patient monitoring system is disclosed. The patch includes a housing configured to be attached to the skin of a patient, the housing containing a radio that can selectably transmit and receive on more than one frequency and a processor. The processor configures the radio to transmit and receive on a determined frequency based at least in part on the level of noise detected on the frequencies.

US Patent:

20120029316, Feb 2, 2012

Filed:

Jul 27, 2010

Appl. No.:

12/844801

Inventors:

Mark Raptis - Valley Center CA, US
Amir Jafri - San Diego CA, US
Ganesh Kathiresan - Osterley, GB
Alison Burdett - Oxford, GB
Okundu Omeni - Hillingdon, GB
Mathew Key - Oxford, GB

Assignee:

CareFusion 303, Inc. - San Diego CA

International Classification:

A61B 5/00

US Classification:

600301

Abstract:

A vital-signs patch for a patient monitoring system is disclosed. The patch consists of a housing that is configured to be worn on the skin of a patient. The housing contains a radio, one or more sensor interfaces, a processor, and a battery. The processor can selectably turn portions of the processor off and on and selectably turn power off and on to at least a portion of the sensor interfaces and radio. The processor includes a timer that, each time the timer times out, will turn all the parts of the processor on and start a new timing period. When the processor receives a signal, the processor will turn off power to at least a portion of the processor and at least a portion of the sensor interfaces.

US Patent:

20120030547, Feb 2, 2012

Filed:

Jul 27, 2010

Appl. No.:

12/844789

Inventors:

Mark Raptis - Valley Center CA, US
Amir Jafri - San Diego CA, US
Alison Burdett - Oxford, GB
Ganesh Kathiresan - Osterley, GB

Assignee:

CareFusion 303, Inc. - San Diego CA

International Classification:

H03M 13/09
G06F 15/16
G06F 11/10
A61B 5/00

US Classification:

714799, 600301, 709204, 714E11032

Abstract:

A vital-signs device in a patient monitoring system is disclosed. The patch includes a housing configured to be attached to the skin of a patient. The housing contain monitoring circuitry configured to acquire and store measurements of vital signs of the patient, a wireless transmitter configured to transmit signals to another device, a wireless receiver configured to receive signals from the other device; and a processor operably connected to the monitoring circuitry, transmitter, and receiver. Upon receipt of an upload signal from the other device, the processor is configured to send a message to the other device via the transmitter. The message packet structure includes a data payload of variable size, a header containing transmit and route information and data payload length, and a data integrity check value.

US Patent:

20220288294, Sep 15, 2022

Filed:

May 25, 2022

Appl. No.:

17/824867

Inventors:

- San Diego CA, US
Matthew ONG - San Diego CA, US
Amir JAFRI - San Diego CA, US
Robert SEGAL - San Diego CA, US
Stephen PRINCE - San Diego CA, US

International Classification:

A61M 1/36
G01N 33/543
G01N 33/68
A61M 1/34
C07K 14/525

Abstract:

The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNFα. The system and method are useful for the treatment of different cancer types, stages and severity.

US Patent:

20220265913, Aug 25, 2022

Filed:

May 5, 2022

Appl. No.:

17/737341

Inventors:

- San Diego CA, US
Matthew ONG - San Diego CA, US
Amir JAFRI - San Diego CA, US
Robert SEGAL - San Diego CA, US
Stephen PRINCE - San Diego CA, US

International Classification:

A61M 1/36
G01N 33/543
G01N 33/68
A61M 1/34
C07K 14/525

Abstract:

The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNFα. The system and method are useful for the treatment of different cancer types, stages and severity.

US Patent:

20220249023, Aug 11, 2022

Filed:

Apr 25, 2022

Appl. No.:

17/728883

Inventors:

- San Diego CA, US
Amir JAFRI - San Diego CA, US
Ganesh KATHIRESAN - Osterley, GB
Alison BURDETT - Oxford, GB

International Classification:

A61B 5/00
A61B 5/01
A61B 5/021
A61B 5/024
A61B 5/08
H04L 1/18
G16H 40/63
G16H 10/60
G16H 40/67
G06F 13/16
H04L 1/00
H04W 56/00
H04W 72/04
H04L 67/125

Abstract:

A vital-signs patch for a patient monitoring system that includes a housing containing a sensor that makes physiological measurements of a patient, a transmitter, a receiver, a memory, and a processor. The processor periodically takes a measurement from the sensor, converts the measurement to a data record, and stores the data record in the memory. Upon receipt of a signal from another device, the processor retrieves at least a portion of the data record, converts the retrieved portion of the data record to a vital-sign signal, and causes the transmitter to transmit the vital-sign signal to the other device.